Sort   by:  
 Page size 
Unknown1263. Assessment of Cefepime (FEP)-Taniborbactam (TAN) Human Exposures to Suppress the Emergence of Resistance among Serine (SBL)- and Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacteria (GNB) in a Hollow Fiber Infection Model (HFIM)
Not available
S-EPMC7776537 | biostudies-literature
UnknownLow-Power Sonication Can Alter Extracellular Vesicle Size and Properties.
Not available
S-EPMC8466153 | biostudies-literature
TranscriptomicsGene expressionprofiling of breast cell lines
We performed gene expression profiling of 31 breast cell lines (BCL) using whole-genome DNA microarrays (Affymetrix U133+2.0) to assessed a better molecular characterization of breast cell lines in order to help discover of new markers to apply to tumour samples.
ORGANISM(S): Homo sapiens 
2013-06-10 | E-MTAB-1693 | biostudies-arrayexpress
UnknownPolycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer.
Not available
S-EPMC4242102 | biostudies-literature
UnknownContiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites.
Not available
S-EPMC4380740 | biostudies-literature
UnknownAntitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding.
Not available
S-EPMC4242090 | biostudies-literature
UnknownLong-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.
Not available
S-EPMC10755216 | biostudies-literature
UnknownIDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.
Not available
S-EPMC3293643 | biostudies-literature
UnknownThe bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Not available
S-EPMC5352346 | biostudies-literature
TranscriptomicsTargeting super-enhancer induced gene expression using novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma
Bromodomain-containing protein 4 (BRD4) functions as an epigenetic reader and binds to so-called super-enhancer regions of driving oncogenes such as MYC in cancer. We investigated the possibility to target super-enhancer regulated genes in neuroblastoma and in MYCN amplified disease in particular. W...
ORGANISM(S): Homo sapiens 
2016-07-03 | E-MTAB-3672 | biostudies-arrayexpress
Sort   by:  
 Page size